CD160-activating NK cell effector functions depend on the phosphatidylinositol 3-kinase recruitment

International Immunology

Volumn 19, Issue 4, 2007, Pages 401-409

  Rabot, Magali ^a   El Costa, Hicham ^a   Polgar, Beata ^a   Marie Cardine, Anne ^a   Aguerre Girr, Maryse ^a   Barakonyi, Aliz ^a   Valitutti, Salvatore ^a   Bensussan, Armand ^a   Le Bouteiller, Philippe ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD160 ANTIGEN; CELL RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; PROTEIN KINASE SYK; PROTEIN KINASE SYK INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXICITY; HUMAN; HUMAN CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD45; CHROMONES; CYTOTOXICITY, IMMUNOLOGIC; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; INTERFERON TYPE II; INTERLEUKIN-6; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KILLER CELLS, NATURAL; MAP KINASE KINASE 1; MAP KINASE KINASE 2; MORPHOLINES; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34047122672     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxm005     Document Type: Article

References (24)

1. Lanier, L. L. 2005. NK cell recognition. Annu. Rev. Immunol. 23:225.
2. Moretta, L., Bottino, C., Pende, D., Vitale, M., Mingari, M. C. and Moretta, A. 2005. Human natural killer cells: Molecular mechanisms controlling NK cell activation and tumor cell lysis. Immunol. Lett. 100:7.
3. Chiesa, S., Mingueneau, M., Fuseri, N. et al. 2006. Multiplicity and plasticity of natural killer cell signaling pathways. Blood 107:2364.
4. Parham, P. 2005. MHC class I molecules and KIRs in human history, health and survival. Nat. Rev. Immunol. 5:201.
5. Bensussan, A. 2000. BY55 (CD160). Protein Rev. Web 1:72.
6. Anumantha, A., Bensussan, A., Boumsell, L. et al. 1998. Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytes. J. Immunol. 161:2780.
7. Giustiniani, J., Marie-cardine, A. and Bensussan, A. 2007. A soluble form of the MHC class I-specific CD160 receptor is released from human activated NK Lymphocytes and inhibits cellmediated cytotoxicity. J Immunol. 178:1293.
8. Le Bouteiller, P., Barakonyi, A., Giustiniani, J. et al. 2002. Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity. Proc. Natl Acad. Sci. USA 99:16963.
9. Barakonyi, A., Rabot, M., Marie-Cardine, A. et al. 2004. Cutting edge: engagement of CD160 by its HLA-C physiological ligand triggers a unique cytokine profile secretion in the cytotoxic peripheral blood NK cell subset. J. Immunol. 173:5349.
10. Maeda, M., Carpetino, C., Russell, R. et al. 2005. Murine CD160, Ig-like receptor on NK cells and NKT cells, recognizes classical and non classical MHC class I and regulates NK cell activation. J. Immunol. 175:4426.
11. Tsujimura, K., Obata, Y., Matsudaira, Y. et al. 2006. Characterization of murine CD160(+) CD8(+) T lymphocytes. Immunol. Lett. 106:48.
12. Lanier, L. L. 2003. Natural killer cell receptor signaling. Curr. Opin. Immunol. 15:308.
13. Upshaw, J. L., Arneson, L. N., Schoon, R. A., Dick, C. J., Billadeau, D. D. and Leibson, P. J. 2006. NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells. Nat. Immunol. 7:524.
14. Vivier, E., Nunes, J. A. and Vely, F. 2004. Natural killer cell signaling pathways. Science 306:1517.
15. Ortaldo, J. R., Winkler-Pickett, R., Wigginton, J. et al. 2006. Regulation of ITAM-positive receptors: Role of IL-12 and IL-18. Blood 107:1468.
16. Stewart, C. A., Vivier, E. and Colonna, M. 2006. Strategies of natural killer cell recognition and signaling. Curr. Top. Microbiol. Immunol. 298:1.
17. Jiang, K., Zhong, B., Gilvary, D. L. et al. 2000. Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells. Nat. Immunol. 1:419.
18. Rincon, M., Flavell, R. A. and Davis, R. J. 2001. Signal transduction by MAP kinases in T lymphocytes. Oncogene 20:2490.
19. MacFarlane, A. W. IV and Campbell, K. S. 2006. Signal transduction in natural killer cells. Curr. Top. Microbiol. Immunol. 298:23.
20. Billadeau, D. D., Upshaw, J. L., Schoon, R. A., Dick, C. J. and Leibson, P. J. 2003. NKG2D-DAP10 triggers human NK cellmediated killing via a Syk-independent regulatory pathway. Nat. Immunol. 4:557.
21. Farag, S. S. and Caligiuri, M. A. 2006. Human natural killer cell development and biology. Blood Rev. 20:123.
22. Lanier, L. 2003. Natural killer cell receptor signaling. Curr. Opin. Immunol. 15:308.
23. Nikolova, M., Marie-Cardine, A., Boumsell, L. and Bensussan, A. 2002. BY55/CD160 acts as a co-receptor in TCR signal transduction of a human circulating cytotoxic effector T lymphocyte subset lacking CD28 expression. Int. Immunol. 14:445.
24. Rabot, M., Bensussan, A. and Le Bouteiller, P. 2006. Engagement of the CD160 activating NK cell receptor leads to its association with CD2 in circulating human NK cells. Transpl. Immunol. 17:36. PI3K-dependent signaling of CD160 NK cell receptor 409